SCHEMBL23212936

SCHEMBL23212936

Cc1ccc(S(=O)(=O)OCCC(CCOS(=O)(=O)c2ccc(C)cc2)c2ccccc2OC(F)(F)F)cc1.OCCC(CCO)c1ccccc1OC(F)(F)F

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RORC P51449 4/20 0.35
LMNA P02545 3/20 0.34
MAPK1 P28482 1/20 0.34
BCHE P06276 1/20 0.34
ACHE P22303 1/20 0.34
GAA P10253 4/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
VDR P11473 1/20 0.33
HCRTR2 O43614 1/20 0.33
ESR1 P03372 1/20 0.33
ESR2 Q92731 1/20 0.33
PPARG P37231 1/20 0.33
PPARD Q03181 1/20 0.33
PPARA Q07869 1/20 0.33
HTT P42858 2/20 0.33
ALDH1A1 P00352 1/20 0.33
TP53 P04637 1/20 0.33
DAGLA Q9Y4D2 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23210224 0.94 BCHE (0.37) RORCLMNAMAPK1BCHEACHE
SCHEMBL29843880 0.94 BCHE (0.37) RORCLMNAMAPK1BCHEACHE
SCHEMBL23212930 0.81 ALDH1A1 (0.36) LMNAMAPK1GAAMEN1KMT2A
SCHEMBL29691204 0.79 KCNK3 (0.38) GAAHTTALDH1A1FFAR4
SCHEMBL23210230 0.79 KCNK3 (0.38) GAAHTTALDH1A1FFAR4
SCHEMBL23212912 0.77 KEAP1 (0.42) LMNAALDH1A1FFAR4
SCHEMBL25817316 0.77 GAA (0.41) MAPK1GAAMEN1KMT2AVDR
SCHEMBL5640238 0.76 CA12 (0.43) RORCLMNAMAPK1BCHEACHE
SCHEMBL23209991 0.76 LMNA (0.48) LMNAMAPK1ALDH1A1
SCHEMBL23213647 0.75 KEAP1 (0.42) LMNAALDH1A1FFAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021070090-A1 2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS NOVARTIS AG (CH) 2021-04-15 WO disclosed